Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1985 Feb;142(2):219-29.

Pathogenesis of impaired glucose tolerance and type II diabetes mellitus--current status

Review

Pathogenesis of impaired glucose tolerance and type II diabetes mellitus--current status

M B Davidson. West J Med. 1985 Feb.

Abstract

The insulin response to glucose taken orally is increased in patients with impaired glucose tolerance (IGT) but decreased in those with type II diabetes mellitus. The insulin response to meals, however, is normal in patients with type II diabetes, although the glucose concentrations are obviously elevated. The acute insulin response to intravenously administered glucose is absent in cases of both IGT and type II diabetes when the fasting plasma glucose level exceeds 115 mg per dl. On the other hand, the response to other intravenously given secretagogues is either normal or nearly so. The absent acute insulin response to intravenously administered glucose can be restored by alpha-adrenergic blockade, prostaglandin synthesis inhibition, dopaminergic blockade and euglycemia. Insulin antagonism characterizes patients with both IGT and type II diabetes. Those with IGT and mild diabetes mellitus (untreated fasting plasma glucose concentrations < 180 mg per dI) have a receptor defect probably due to down regulation. Diabetic patients with more severe type II diabetes show a postreceptor defect. The relation (if any) between receptor and postreceptor defects is unclear.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Invest. 1967 Oct;46(10):1549-57 - PubMed
    1. Diabetes. 1969 Apr;18(4):216-24 - PubMed
    1. J Clin Invest. 1970 Dec;49(12):2151-60 - PubMed
    1. J Clin Invest. 1970 Dec;49(12):2276-80 - PubMed
    1. Metabolism. 1971 Nov;20(11):1000-7 - PubMed

LinkOut - more resources